Catalyst Wire Dossier Catalyst Wire Dossier

Pradaxa Pellets

dabigatran etexilate · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pradaxa Pellets, covering 2025-09-04 to 2026-06-02. Get the full timeline:

Most recent: Clinical Trial Results: A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

See pricing